Glycerophosphoinositols as potential markers of ras-induced transformation and novel second messengers

Anticancer Research

Volumn 16, Issue 3 B, 1996, Pages 1341-1350

  Corda, Daniela ^a,b   Falasca, Marco ^a  

^a Lab of Cell and Molec Endocrinol   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

Adenylyl cyclase; cAMP; Cell proliferation; Differentiation; Glycerophosphoinositols; Growth factors; Inositol phosphates; Lysolipase; Lysophosphatidylinositol; Phospholipases; Ras

Indexed keywords

ADENYLATE CYCLASE; GLYCEROPHOSPHORYLINOSITOL 4 PHOSPHATE; INOSITOL PHOSPHATE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE A2;

CELL MEMBRANE; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; HORMONAL REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NERVE CELL; ONCOGENE RAS; PRIORITY JOURNAL; SECOND MESSENGER; THYROID CELL;

ANIMALS; BIOLOGICAL MARKERS; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMANS; INOSITOL PHOSPHATES; PHOSPHOLIPASES; SECOND MESSENGER SYSTEMS;

EID: 0030036057     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (86)

1. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995.
2. Casey PJ: Protein lipidation in cell signaling. Science 268: 221-225, 1995.
3. Milligan G, Parents M, Magee AI: The dynamic role of palmitoylation in signal transduction. Trends Biochem Sci 20: 181-186, 1995.
4. Liscovitch M, Cantley LC: Signal transduction and membrane traffic: the PITP/phosphoinositide connection. Cell 81: 659-662, 1995.
5. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
6. Divecha N, Irvine RF: Phospholipid signaling. Cell 80: 269-278, 1995.
7. Bell RM, Burns DJ: Lipid activation of protein kinase C. J Biol Chem 266: 4661-4664, 1991.
8. Billah MM: Phospholipase D and cell signaling. Curr Opin Immunol 5: 114-123, 1993.
9. Moolenaar WH: Lysophosphatidic acid signalling. Curr Opin Cell Biol 7: 203-210, 1995.
10. Pushkareva M, Obeid LM, Hannun YA: Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol Today 16: 294-297, 1995.
11. Panayotou G, Walerfield MD: Phosphatidylinositol 3-kinase: a key enzyme in diverse signalling processes. Trends Cell Biol 2: 358-360, 1992.
12. Hannun YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125-3128, 1994.
13. Su Y, Rosenthal D, Smulson M, Spiegel S: Sphingosine 1-phosphate, a novel signaling molecule, stimulates DNA binding activity of AP-1 in quiescent Swiss 3T3 fibroblasts. J Biol Chem 269: 16512-16517, 1994.
14. Cuadrado A, Carnero A, Dolfi F, Jiménez B, Lacal JC: Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene 8: 2959-2968, 1993.
15. Falasca M, Carvelli A, Iurisci C, Corda D: Growth-factor-induced-formation of glycerophosphoinositol-4-phosphate, a putative novel intrecellular messenger that inhibits adenylyl-cyclase activity. (Submitted).
16. Alonso T, Morgan RO, Marvizon JC, Zarbl H, Santos E: Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways. Proc Natl Acad Sci USA 85: 4271-4275, 1988.
17. Alonso T, Santos E: Increased intracellular glycerophosphoinositol is a biochemical marker for transformation by membrane-associated and cytoplasmic oncogenes. Biochem Biophys Res Commun 171: 14-19, 1990.
18. 2 activity, glycerophosphoinositol production and phosphoinositide synthesis in thyroid cells. Cell Signal 3: 321-332, 1991.
19. Iacovelli L, Falasca M, Valitutti S, D'Arcangelo D, Corda D: Glycerophosphoinositol 4-phosphate, a putative endogenous inhibitor of adenylylcyclase. J Biol Chem 268: 20402-20407, 1993.
20. 2 hydrolysis and regulation of phospholipase C isozymes. Curr Opin Cell Biol 7: 183-189, 1995.
21. Cockcroft S, Thomas GMH: Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J 288: 1-14, 1992.
22. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 361: 315-325, 1993.
23. 2 enzymes: regulation and inhibition. Trends Pharmacol Sci 14: 92-98, 1993.
24. Exton JH: Signaling through phosphatidylcholine breakdown. J Biol Chem 265: 1-4, 1990.
25. Dennis EA, Rhee SG, Billah MM, Hannun YA: Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J 5: 2068-2077, 1991.
26. 2 (s); comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J 7: 339-348, 1993.
27. 2. J Biol Chem 269: 13057-13060, 1994.
28. Piomelli D, Greengard P: Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. Trends Pharmacol Sci 11: 367-373, 1990.
29. Piomelli D: Arachidonic acid in cell signaling. Curr Opin Cell Biol 5: 274-280, 1993.
30. Khan WA, Blobe GC, Hannun YA: Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell Signal 7: 171-184, 1995.
31. Moolenaar WH: Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270: 12949-12952, 1995.
32. Falasca M, Corda D: Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells. Eur J Biochem 221: 383-389, 1994.
33. Asaoka Y, Oka M, Yoshida K, Nishizuka Y: Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation. Biochem Biophys Res Commun 178: 1378-1381, 1991.
34. van der Bend R, Brunner J, Jalink K, van Corven EJ, Moolenaar WH, van Blitterswijk WJ: Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J 11: 2495-2501, 1992.
35. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH: The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291: 677-680, 1993.
36. Falasca M and Corda D: Accumulation and mitogenic activity of lysophosphatidylinositol in k-ras-transformed thyroid cells. In: Molecular Oncology and Clinical Applications (Cittadini A, Baserga R, Pinedo H, Galeotti T, and Corda D, eds). Basel, Birkhauser Verlag, 1993, pp 165-171.
37. Falasca M, Silletta MG, Carvelli A, et al: Signalling pathways involved in the mitogenic action of lysophosphatidylinositol. Oncogene 10: 2113-2124, 1995.
38. 2 and lysophospholipids on insulin secretion. Endocrinology 120: 1750-1757, 1987.
39. 2+ by lysophospholipids in rat islets of langerhans. Biochim Biophys Acta 968: 239-252, 1988.
40. Tsai M-H, Yu C-L, Wei F-S, Stacey DW: The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids. Science 243: 522-526, 1989.
41. 2 in signal transduction through protein kinase C. Proc Natl Acad Sci USA 89: 6447-6451, 1992.
42. 2 in HL-60 cell differentiation to macrophages induced by protein kinase C activation. Proc Natl Acad Sci USA 90: 4917-4921, 1993.
43. Ross TS, Majerus PW: Inositol-1,2-cyclic-phosphate 2-inositol-phosphohydrolase. J Biol Chem 266: 851-856, 1991.
44. Lacal JC, Carnero A: Regulation of Ras proteins and their involvement in signal transduction pathways. Oncol Rep 1: 677-693, 1994.
45. Lowe PN, Skinner RH: Regulation of ras signal transduction in normal and transformed cells. Cell Signal 6: 109-123, 1994.
46. Bar-Sagi D, Feramisco JR: Induction of membrane ruffling and fluidphase pinocytosis in quiescent fibroblasts by ras proteins. Science 233: 1061-1068, 1986.
47. 2 in normal and ras-transformed cells. J Cell Biol 106: 1649-1658, 1988.
48. Sharma SV: Melittin resistance: a counterselection for ras transformation. Oncogene 7: 193-201, 1992.
49. Bunce CM, French PJ, Allen P, et al. Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts. Biochem J 289: 667-673, 1993.
50. Teegarden D. Taparowsky EJ, Kent C: Altered phosphatidylcholine metabolism in C3H10T1/2 cells transfected with the harvey-ras oncogene. J Biol Chem 265: 6042-6047, 1990.
51. Mountford JC, Bunce CM, French PJ, Michell RH, Brown G: Intracellular concentrations of inositol, glycerophosphoinositol and inositol pentakisphosphate increase during haemopoietic cell differentiation. Biochim Biophys Acta 1222: 101-108, 1994.
52. French PJ, Bunce CM, Stephens LR, et al: Changes in the levels of inositol lipids and phosphates during the differentiation of HL60 promyelocytic cells towards neutrophils or monocytes. Proc R Soc Lond 245: 193-201, 1991.
53. Falasca M, Marino M, Carvelli A, Iurisci C, Leoni S, Corda D: High levels of glycerophosphoinositol characterize the undifferentiated state of neuronal (NG108-15) and hepatic cells. Eur J Biochem in press.
54. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
55. 2. In: GTPase-controlled molecular machines (Corda D, Hamm H and Luini A, eds). Roma, Ares-Serono Symposia Publications, 1994, pp 79-91.
56. Falasca M, Iurisci C, Carvelli A, Corda D: Evidence that glycerophosphoinositol-4-phosphate is a novel second messenger. Pharmacol Res 31(suppl): 176, 1995.
57. Bender JL, Neer EJ: Properties of the adenylate cyclase catalytic unit from caudate nucleus. J Biol Chem 258: 2432-2439, 1983.
58. McHugh Sutkowski E, Tang W-J, Broome CW, Robbins JD, Seamon KB: Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gsα. Biochemistry 33: 12852-12859, 1994.
59. 3H] forskolin to human platelet membranes. J Biol Chem 261: 13469-13473, 1986.
60. Spiegel AM, Shenker A, Weinstein LS: Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr Rev 13: 536-565, 1992.
61. Corda D, Falasca M, Di Girolamo M and Cacciamani T: Phospholipases in signal transduction. In: Biomembranes. Signal Transduction Across Membranes (Shinitzky M, ed). Weinheim, VCH Verlagsgesellschaft, 1995, pp 283-317.
62. Birnbaumer L, Abramowitz J, Brown AM: Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031: 163-224, 1990.
63. Neer EJ: Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80: 249-257, 1995.
64. Sho K, Okajima F, Abdul Majid M, Kondo Y: Reciprocal modulation of thyrotropin actions by P1-purinergic agonists in FRTL-5 thyroid cells. J Biol Chem 266: 12180-12184, 1991.
65. 2-purinergic stimulation of phosphoinositide turnover and arachidonate release in FRTL-5 thyroid cells. J Biol Chem 264: 13029-13037, 1989.
66. 2. Mol Neurobiol 3: 155-171, 1989.
67. 1-adrenergic stimulation in FRTL5 thyroid cells. Proc Natl Acad Sci USA 83: 7201-7205, 1986.
68. Corda D, Kohn LD: Role of pertussis toxin sensitive G proteins in the alpha 1 adrenergic receptor but not in the thyrotropin receptor mediated activation of membrane phospholipases and iodide fluxes in FRTL-5 thyroid cells. Biochem Biophys Res Commun 141: 1000-1006, 1986.
69. 2 and inhibitory regulation of PLC. In: Handbook of experimental pharmacology: GTPases in Biology II (Dickey BF and Birnbaumer L, eds). Heidelberg, Springer-Verlag, 1993, pp 387-400.
70. Corda D, Bizzarri C, Di Girolamo M, Valitutti S, Luini A: G protein-linked receptors in the thyroid. Adv Exp Med Biol 261: 245-269, 1989.
71. 2 by glycerophosphoinositols. (Submitted).
72. Irvine RF: Functions of inositol phosphates. In: Inositol lipids in cell signalling (Michell RH, Drummond AH and Downes CP, eds). London, Academic Press, 1989, pp 135-161.
73. Cubitt AB, Thaw CN, Gershengorn MC: 5′-CMP stimulates phospholipase A-mediated hydrolysis of phosphatidylinositol in permeabilized pituitary GH3 cells. Biochem J 278: 831-834, 1991.
74. Taguchi M, Field JB: Phosphoinositides metabolism in primary culture of dog thyroid cells: effects of thyrotropin and carbachol. Metabolism 39: 418-424, 1990.
75. Gandhi CR, Stephenson K, Olson MS: A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J 281: 485-492, 1992.
76. Gandhi CR, Hanahan DJ, Olson MS: Two distinct pathways of platelet-activating factor-induced hydrolysis of phosphoinositides in primary cultures of rat Kupffer cells. J Biol Chem 265: 18234-18241, 1990.
77. Senar S, Puente JC, López-Aparicio P, Recio MN, Pérez-Albarsanz MA: Increased intracellular glycerophosphoinositol and arachidonic acid are biochemical markers for lindane toxicity. Cell Signal 6: 915-921, 1994.
78. Angus WW, Lester RL: Turnover of inositol and phosphorus containing lipids in Saccharomyces cerevisiae; extracellular accumulation of glycerophosphorylinositol derived from phosphatidylinositol. Arch Biochem Biophys 151: 483-495, 1972.
79. Angus WW, Lester RL: The regulated catabolism of endogenous and exogenous phosphatidylinositol by Saccharomyces cerevisiae leading to extracellular glycerophosphorylinositol and inositol. J Biol Chem 250: 22-30, 1975.
80. Paltauf F, Zinser E, Daum G: Utilization of exogenous glycerophosphodiesters and glycerol-3-phosphate by inositol-starved yeast. Saccharomyces uvarum. Biochim Biophys Acta 835: 322-330, 1985.
81. Hawkins PT, Stephens LR, Piggott JR: Analysis of inositol metabolites produced by Saccharomyces cerevisiae in response to glucose stimulation. J Biol Chem 268: 3374-3383, 1993.
82. Patton JL, Pessoa-Brandao L, Henry SA: Production and reutilization of an extracellular phosphatidylinositol catabolite, glycerophosphoinositol, by Saccharomyces cerevisiae. J Bacteriol 177: 3379-3385, 1995.
83. Cruz-Rivera M, Bennett CF, Crooke ST: Glycerol-3-phospho-D-myoinositol 4-phosphate (Gro-PIP) is an inhibitor of phosphoinositide-specific phospholipase C. Biochim Biophys Acta 1042: 113-118, 1990.
84. Luciani S, Antolini M, Bova S, et al. Inhibition of cardiac sarcolemmal sodium-calcium exchanger by glycerophosphoinositol 4-phosphate and glycerophosphoinositol 4-5-bisphosphate. Biochem Biophys Res Commun 206: 674-680, 1995.
85. Burgering BMT, Bos JL: Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem Sci 20: 18-22, 1995
86. Peppelenbosch MP, Oiu R-G, de Vries-Smits AMM, et al: Rac mediates growth factor-induced arachidonic acid release. Cell 81: 849-856, 1995.